No statistically significant benefit was observed for sudden cardiac death (ARR=0.022, NNT=45), though the point estimate suggests a possible trend.
← all excerpts
Adjunctive Tongxinluo capsule for patients with acute coronary syndromes undergoing percutaneous coronary intervention: a GRADE-assessed systematic review and meta-analysis of randomised controlled trials.
1
—
—